Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma
This study has been withdrawn prior to enrollment.
( unable to enroll subjects into the study )
Study NCT00469469   Information provided by Dartmouth-Hitchcock Medical Center

First Received on May 2, 2007.   Last Updated on May 23, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Adrenocortical Carcinoma
Additional conditions recognized in this trial
Adrenal Cortex Neoplasms
Carcinoma
More general conditions related to this trial
Adenocarcinoma
Adrenal Cortex Diseases
Adrenal Gland Diseases
Adrenal Gland Neoplasms
Endocrine Gland Neoplasms
Endocrine System Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Interventions listed in this trial
Bevacizumab
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antineoplastic Agents
Growth Inhibitors
Growth Substances
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Dartmouth-Hitchcock Medical Center
Genentech


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services